Dr. Greg Grosicki, a senior research scientist at WHOOP with a PhD in Human Bioenergetics and a passion for exercise physiology, sheds light on GLP-1 medications. He discusses their influence on weight loss and heart health, as well as the critical interplay between these treatments and exercise. The conversation explores the rising popularity of GLP-1 medications for obesity, the challenges in accessibility, and the importance of combining them with lifestyle changes. Greg also highlights how WHOOP's data can enhance our understanding of these therapies.